InnovaRx Innova Health Strategies

G71.12

Myotonia congenita

Billable FY2026 2025-10-01 → 2026-09-30
Exclusions 11 never code together
G71code
Excludes2
  • arthrogryposis multiplex congenita (Q74.3)Q74.3
  • metabolic disorders (E70-E88)E70-E88
  • myositis (M60.-)M60.-
G00-G99chapter
Excludes2
  • certain conditions originating in the perinatal period (P04-P96)P04-P96
  • certain infectious and parasitic diseases (A00-B99)A00-B99
  • complications of pregnancy, childbirth and the puerperium (O00-O9A)O00-O9A
  • congenital malformations, deformations, and chromosomal abnormalities (Q00-Q99)Q00-Q99
  • endocrine, nutritional and metabolic diseases (E00-E88)E00-E88
  • injury, poisoning and certain other consequences of external causes (S00-T88)S00-T88
  • neoplasms (C00-D49)C00-D49
  • symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)R00-R94

Excludes2 — not included here, but the patient may have both. Code both when documented.

Instructional notes 4
G71.12code
Inclusion terms
  • Acetazolamide responsive myotonia congenita
  • Dominant myotonia congenita [Thomsen disease]
  • Myotonia levior
  • Recessive myotonia congenita [Becker disease]
Index entries leading here 4
  • Disease, diseased — see also Syndrome
  • Becker's
    • disease
      • myotonia congenita, recessive form G71.12
  • Myotonia (acquisita) (intermittens) M62.89
    • congenita (acetazolamide responsive) (dominant) (recessive) G71.12
    • levior G71.12
  • Thomsen disease G71.12
Alongside this code 4 same parent — G71.1
Additional references
AHA Coding Clinic® Licence required

Official coding advice for this code. Published by the American Hospital Association. Not included in this installation.

Risk adjustment

ESRD21HCC75

Presence is a property of the code. Untick a model to hide it everywhere.

This code

Billable
yes
Code set
FY2026
Parent
G71.1
Block
G70-G73
Siblings
4

Present FY2024–FY2027.